(COVID Version) Global Biosimilar Drug Market Status (2017-2022) and Forecast (2022E-2028F) by Region, Product Type & End-Use
- Published Date : 30-05-2022
- Pages : 113
- Report Id : 35872
- Categories : Healthcare
Summary
The report forecast global Biosimilar Drug market to grow to reach xxx Million USD in 2022 with a CAGR of xx% during the period 2022E-2028F due to coronavirus situation.
The report offers detailed coverage of Biosimilar Drug industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Biosimilar Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Biosimilar Drug market for 2018-2027.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Biosimilar Drug according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Biosimilar Drug company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent
Market by Type
Injection
Tablets
Other Types
Market by Application
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Others
Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Biosimilar Drug
Figure Global Biosimilar Drug Market Share by Type in 2022
1.4 By Application
Table Application of Biosimilar Drug
Figure Global Biosimilar Drug Market Share by Application in 2022
1.5 By Region
Figure Global Biosimilar Drug Market Share by Region in 2022
Figure Asia Biosimilar Drug Market Share by Region in 2022
Part 2 Key Companies
2.1 CP Guojian Pharma
2.1.1 Company Profile
Table CP Guojian Pharma Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Biosimilar Drug Business Operation of CP Guojian Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Biotech Pharma
2.3 Celgen Pharma
2.4 Henlius
2.5 Amgen
2.6 Eli Lilly
2.7 Sandoz
2.8 Changchun High Tech
2.9 Innovent
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Biosimilar Drug Market by Region, 2017-2022 (Million USD)
Figure Global Biosimilar Drug Market Share by Region in 2022 (Million USD)
Table Global Biosimilar Drug Market by Region, 2017-2022 (Volume)
Figure Global Biosimilar Drug Market Share by Region in 2022 (Volume)
Table Price List by Region, 2017-2022
3.2 Global Market by Company
Table Global Biosimilar Drug Market by Company, 2017-2022 (Million USD)
Figure Global Biosimilar Drug Market Share by Company in 2022 (Million USD)
Table Global Biosimilar Drug Market by Company, 2017-2022 (Volume)
Figure Global Biosimilar Drug Market Share by Company in 2022 (Volume)
Table Price List by Company, 2017-2022
3.3 Global Market by Type
Table Global Biosimilar Drug Market by Type, 2017-2022 (Million USD)
Figure Global Biosimilar Drug Market Share by Type in 2022 (Million USD)
Table Global Biosimilar Drug Market by Type, 2017-2022 (Volume)
Figure Global Biosimilar Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
3.4 Global Market by Application
Table Global Biosimilar Drug Market by Application, 2017-2022 (Million USD)
Figure Global Biosimilar Drug Market Share by Application in 2022 (Million USD)
Table Global Biosimilar Drug Market by Application, 2017-2022 (Volume)
Figure Global Biosimilar Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
3.5 Global Market by Forecast
Figure Global Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Global Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Biosimilar Drug Market by Type, 2017-2022 (Million USD)
Figure Asia-Pacific Biosimilar Drug Market Share by Type in 2022 (Million USD)
Table Asia-Pacific Biosimilar Drug Market by Type, 2017-2022 (Volume)
Figure Asia-Pacific Biosimilar Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Biosimilar Drug Market by Application, 2017-2022 (Million USD)
Figure Asia-Pacific Biosimilar Drug Market Share by Application in 2022 (Million USD)
Table Asia-Pacific Biosimilar Drug Market by Application, 2017-2022 (Volume)
Figure Asia-Pacific Biosimilar Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure China Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure China Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure China Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Southeast Asia Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Southeast Asia Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Southeast Asia Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure India Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure India Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure India Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Japan Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Japan Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Japan Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Korea Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Korea Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Korea Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Oceania Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Oceania Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Oceania Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Asia-Pacific Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Biosimilar Drug Market by Type, 2017-2022 (Million USD)
Figure Europe Biosimilar Drug Market Share by Type in 2022 (Million USD)
Table Europe Biosimilar Drug Market by Type, 2017-2022 (Volume)
Figure Europe Biosimilar Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
5.2 Europe Market by Application
Table Europe Biosimilar Drug Market by Application, 2017-2022 (Million USD)
Figure Europe Biosimilar Drug Market Share by Application in 2022 (Million USD)
Table Europe Biosimilar Drug Market by Application, 2017-2022 (Volume)
Figure Europe Biosimilar Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Germany Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Germany Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Germany Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure UK Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure UK Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure UK Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure France Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure France Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure France Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Italy Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Italy Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Italy Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Russia Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Russia Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Russia Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Spain Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Spain Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Spain Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Netherlands Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Netherlands Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Netherlands Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Turkey Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Turkey Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Turkey Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Switzerland Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Switzerland Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Switzerland Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
5.4 Europe Market by Forecast
Figure Europe Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Europe Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Biosimilar Drug Market by Type, 2017-2022 (Million USD)
Figure North America Biosimilar Drug Market Share by Type in 2022 (Million USD)
Table North America Biosimilar Drug Market by Type, 2017-2022 (Volume)
Figure North America Biosimilar Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
6.2 North America Market by Application
Table North America Biosimilar Drug Market by Application, 2017-2022 (Million USD)
Figure North America Biosimilar Drug Market Share by Application in 2022 (Million USD)
Table North America Biosimilar Drug Market by Application, 2017-2022 (Volume)
Figure North America Biosimilar Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure United States Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure United States Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure United States Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Canada Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Canada Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Canada Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Mexico Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Mexico Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Mexico Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
6.4 North America Market by Forecast
Figure North America Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure North America Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Biosimilar Drug Market by Type, 2017-2022 (Million USD)
Figure South America Biosimilar Drug Market Share by Type in 2022 (Million USD)
Table South America Biosimilar Drug Market by Type, 2017-2022 (Volume)
Figure South America Biosimilar Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
7.2 South America Market by Application
Table South America Biosimilar Drug Market by Application, 2017-2022 (Million USD)
Figure South America Biosimilar Drug Market Share by Application in 2022 (Million USD)
Table South America Biosimilar Drug Market by Application, 2017-2022 (Volume)
Figure South America Biosimilar Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Brazil Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Brazil Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Brazil Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Argentina Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Argentina Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Argentina Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Columbia Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Columbia Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Columbia Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Chile Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Chile Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Chile Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure Peru Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure Peru Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Peru Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
7.4 South America Market by Forecast
Figure South America Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure South America Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Biosimilar Drug Market by Type, 2017-2022 (Million USD)
Figure Middle East & Africa Biosimilar Drug Market Share by Type in 2022 (Million USD)
Table Middle East & Africa Biosimilar Drug Market by Type, 2017-2022 (Volume)
Figure Middle East & Africa Biosimilar Drug Market Share by Type in 2022 (Volume)
Table Price List by Type, 2017-2022
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Biosimilar Drug Market by Application, 2017-2022 (Million USD)
Figure Middle East & Africa Biosimilar Drug Market Share by Application in 2022 (Million USD)
Table Middle East & Africa Biosimilar Drug Market by Application, 2017-2022 (Volume)
Figure Middle East & Africa Biosimilar Drug Market Share by Application in 2022 (Volume)
Table Price List by Application, 2017-2022
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure GCC Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure GCC Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure GCC Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure North Africa Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure North Africa Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure North Africa Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Biosimilar Drug Market Market Status, 2017-2022 (Million USD)
Figure South Africa Biosimilar Drug Market Market Status, 2017-2022 (Volume)
Figure South Africa Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure South Africa Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Biosimilar Drug Market Forecast, 2022E-2028F (Million USD)
Figure Middle East & Africa Biosimilar Drug Market Forecast, 2022E-2028F (Volume)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion
Direct Purchase
Your perfect start with Stats And ResearchWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Stats And Research Copyright © 2024 .